1. Home
  2. GAIA vs GANX Comparison

GAIA vs GANX Comparison

Compare GAIA & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.41

Market Cap

70.9M

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.74

Market Cap

78.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
GANX
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
78.2M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
GAIA
GANX
Price
$2.41
$1.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.50
$7.50
AVG Volume (30 Days)
72.2K
495.6K
Earning Date
05-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
31.46
EPS
N/A
N/A
Revenue
$4,500,000.00
$55,180.00
Revenue This Year
$13.07
N/A
Revenue Next Year
$12.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.50
N/A
52 Week Low
$2.30
$1.41
52 Week High
$6.39
$4.34

Technical Indicators

Market Signals
Indicator
GAIA
GANX
Relative Strength Index (RSI) 40.58 43.30
Support Level $2.37 $1.60
Resistance Level $3.41 $2.09
Average True Range (ATR) 0.19 0.10
MACD -0.02 -0.01
Stochastic Oscillator 11.73 47.62

Price Performance

Historical Comparison
GAIA
GANX

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: